# Effects of Pioglitazone on Stress Reactivity and Alcohol Craving (Pilot)

> **NCT03860753** · PHASE1,PHASE2 · TERMINATED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 4 (actual)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03860753
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-01
- **Primary completion:** 2019-08-23
- **Final completion:** 2019-08-23
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Halted enrollment due to COVID-19
- **Last updated:** 2020-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03860753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03860753, "Effects of Pioglitazone on Stress Reactivity and Alcohol Craving (Pilot)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03860753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*